Neumora Therapeutics, Inc. Common Stock (NMRA)
Largest Insider Buys in Sector
NMRA Stock Price History Chart
NMRA Stock Performance
About Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in …
Insider Activity of Neumora Therapeutics, Inc. Common Stock
Over the last 12 months, insiders at Neumora Therapeutics, Inc. Common Stock have bought $0 and sold $1.45M worth of Neumora Therapeutics, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Neumora Therapeutics, Inc. Common Stock have bought $63.05M and sold $1.45M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,357 shares for transaction amount of $40,217 was made by Burow Kristina () on 2023‑11‑14.
List of Insider Buy and Sell Transactions, Neumora Therapeutics, Inc. Common Stock
| 2024-10-18 | Sale | director | 14,049 0.0149% | $17.03 | $239,319 | -34.23% | ||
| 2024-10-17 | Sale | director | 7,739 0.0082% | $17.01 | $131,643 | -36.03% | ||
| 2024-10-10 | Sale | Head of R&D | 8,260 0.0078% | $15.09 | $124,603 | -28.44% | ||
| 2024-10-09 | Sale | Head of R&D | 5,563 0.0052% | $15.01 | $83,507 | -21.94% | ||
| 2024-09-18 | Sale | Head of R&D | 10,676 0.008% | $12.09 | $129,091 | -1.23% | ||
| 2024-09-17 | Sale | Head of R&D | 30,788 0.0226% | $11.81 | $363,736 | +4.09% | ||
| 2024-09-12 | Sale | Head of R&D | 32,948 0.0235% | $11.43 | $376,665 | +1.31% | ||
| 2023-11-14 | 3,357 0.0025% | $11.98 | $40,217 | +3.37% | ||||
| 2023-11-14 | 10 percent owner | 3,357 0.0025% | $11.98 | $40,217 | +3.37% | |||
| 2023-11-13 | 31,653 0.0232% | $11.75 | $371,923 | +2.51% | ||||
| 2023-11-13 | 10 percent owner | 31,653 0.0232% | $11.75 | $371,923 | +2.51% | |||
| 2023-11-10 | 17,275 0.0124% | $11.49 | $198,481 | +5.87% | ||||
| 2023-11-10 | 10 percent owner | 17,275 0.0124% | $11.49 | $198,481 | +5.87% | |||
| 2023-11-09 | 31,079 0.0204% | $10.53 | $327,262 | +15.57% | ||||
| 2023-11-09 | 10 percent owner | 31,079 0.0204% | $10.53 | $327,262 | +15.57% | |||
| 2023-11-08 | 92,251 0.0634% | $11.03 | $1.02M | +15.05% | ||||
| 2023-11-08 | 10 percent owner | 92,251 0.0634% | $11.03 | $1.02M | +15.05% | |||
| 2023-11-07 | 30,192 0.0216% | $11.50 | $347,208 | +5.26% | ||||
| 2023-11-07 | 10 percent owner | 30,192 0.0216% | $11.50 | $347,208 | +5.26% | |||
| 2023-11-06 | 43,082 0.031% | $11.55 | $497,597 | +6.66% |
Insider Historical Profitability
| Burow Kristina | 4131207 2.5571% | $10.85 | 15 | 0 | +3% | |
| ARCH Venture Partners XII, LLC | 10 percent owner | 4131207 2.5571% | $10.85 | 14 | 0 | +3.29% |
| ARCH Venture Partners X, LLC | 10 percent owner | 3624143 2.2432% | $10.85 | 1 | 0 | <0.0001% |
| Gosebruch Henry O | President & CEO | 15000 0.0093% | $10.85 | 1 | 0 | <0.0001% |